Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polymer Laboratories was a leading specialist in the design and manufacture of high-performance chromatography columns, media, and instrumentation, particularly for Gel Permeation Chromatography (GPC) and Size Exclusion Chromatography (SEC). Founded in 1976, the company became renowned for its expertise in polymer characterization and the development of specialized resins for solid-phase synthesis and purification. Its core product lines, including the PLgel and PLaquagel series, became industry standards for analyzing the molecular weight distribution of synthetic and biopolymers. Following its acquisition by Varian in 2005 and subsequently by Agilent Technologies in 2010, the company's technology was fully integrated into Agilent's liquid chromatography portfolio. Today, the legacy of Polymer Laboratories continues to support pharmaceutical and materials science research through Agilent's market-leading GPC/SEC solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polymer Laboratories.